RXDX — Prometheus Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge Cap

Annual balance sheet for Prometheus Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	10.9	4.45	54.2	257	696
Net Total Accounts Receivable
Net Total Receivables	—	0	1.09	1.08	1.03
Prepaid Expenses
Total Other Current Assets
Total Current Assets	11	37.5	57.5	265	708
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.077	0.321	0.447	1.45	31.7
Net Intangible Assets
Other Long Term Assets
Total Assets	11.1	50.5	59.6	268	741
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.25	31.9	15.3	16.4	22.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.25	43.7	31.2	32.6	64.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	9.86	6.77	28.5	235	676
Total Liabilities & Shareholders' Equity	11.1	50.5	59.6	268	741
Total Common Shares Outstanding